David Henry's JCSO Podcast

David Henry's JCSO podcast, October 2016


 

In the October podcast for The Journal of Community and Supportive Oncology, the Editor-in-Chief, Dr David Henry, discusses Original Reports on toxicity analysis of docetaxel, cisplatin, and 5-fluorouracil neoadjuvant chemotherapy in Indian patients with head and neck cancers and on the impact of a literacy-sensitive intervention on CRC screening knowledge, attitudes, and intention to screen as well as an editorial by JCSO Editor Jame Abraham on lessons learned from using CDK 4/6 inhibitors to treat metastatic breast cancer. Also up for discussion are the approval of cabozantinib for renal cell carcinoma, and two Case Reports on central nervous system manifestations of multiple myeloma and on primary chest-wall leiomyosarcoma. Rounding out the discussion are two featured articles, one on new therapies for urologic cancers and another on a step-by-step guide for doctors who want to take to the Twittersphere.

Listen to the podcast below.

Recommended Reading

FDA approves atezolizumab for advanced NSCLC
MDedge Hematology and Oncology
CMS offering educational webinars on MACRA
MDedge Hematology and Oncology
Access issues looming as more docs eye exit from clinical practice
MDedge Hematology and Oncology
Analysis: CMS expects no MACRA pay cut for most small practices
MDedge Hematology and Oncology
Medicare subsidies eliminate disparities in adherence to hormonal
MDedge Hematology and Oncology
Texas medical board drops appeal against Teladoc
MDedge Hematology and Oncology
FDA issues warning about radiation therapy devices
MDedge Hematology and Oncology
Combos produce ‘encouraging’ responses in MM
MDedge Hematology and Oncology
Drug fails to meet endpoint in phase 3 ITP trial
MDedge Hematology and Oncology
Speaker says use the best regimen ASAP in MM
MDedge Hematology and Oncology